Vista Therapeutics has been developing, collaborating, and fine tuning the NanoBioSensorTM Platform based on research developed in the Charles M. Lieber Laboratory at Harvard University. The software, instrument, and functionalized NanoCards for target immobilization are based on silicon nanowires that act as Field Effect Transistors (FETs) to quantitatively measure and provide kinetic analysis of real time changes in conductance with high sensitivity based on detector:target sample interactions without requiring secondary detection molecules. Applications include: -Multiplex biomarker measurement in body fluids and cell culture matrices -Bioprocess monitoring -Toxicology/Pharmacokinetics -Portable option for field based diagnostics -Pathogen detection -Environmental monitoring -Historical exposure/vaccine analyis (IgM or IgG formation) -PCR/rtPCR coming soon...